Michael Scolaro

Michael Scolaro

Sep 23, 2017

Group 6 Copy 259
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    How does sleep deprivation impact problematic eating?

    Research studies have linked characteristics of eating disorders (e.g., binge eating, extreme dieting) with...

    How does taking Ritalin affect depersonalization-derealization disorder patients?

    We are investigating Ritalin's role in alleviating symptoms of depersonalization-derealization (DPDR) disorder...

    Are Implanted Prosthetic Legs for Horses Possible?

    An unacceptable number of otherwise healthy horses are euthanized each year from lower limb ailments for...

    Backer Badge Funded